CG
LEGN icon

Carmignac Gestion’s Legend Biotech LEGN Stock Holding History

Carmignac Gestion’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,000
Closed -$213K – 141
2020
Q2 		$213K Buy
+5,000
New +$195K ﹤0.01% 121

Other funds holding LEGN

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Carmignac Gestion's LEGN Position: Q3 2020 in Review

Carmignac Gestion sold out of Legend Biotech (LEGN) in Q3 2020, closing a stake of 5,000 shares — an estimated $213K sold.

Carmignac Gestion first reported a position in LEGN in Q2 2020 and held it in 1 quarter. The position peaked at $213K in Q2 2020. 50 funds tracked by Wall St. Rank hold LEGN as of Q3 2020.

  • Carmignac Gestion reported no remaining Legend Biotech position as of Q3 2020 after selling out during the quarter.
  • Carmignac Gestion sold 5,000 Legend Biotech shares in Q3 2020, an estimated $213K.
  • Carmignac Gestion first reported a position in Legend Biotech in Q2 2020 and held it in 1 quarter.
  • Carmignac Gestion's Legend Biotech position peaked at $213K in Q2 2020.
  • 50 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2020.

Based on Carmignac Gestion's 13F filing for Q3 2020, filed 13 Nov 2020.